Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2024-05-21 00:00:00 ET · period of report 2024-05-19 · accession 0001415889-24-014009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-21 | 2024-05-19 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | F - Tax | $43.48 | -387 | 97.3K | -0.4% | -$16.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-19 | F | D | 387 | $43.48 | 97,268 | D | — | — | (F1) The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs. |